Global Molecular Infectious Disease Testing Market OverviewThe global molecular infectious disease testing market is ...

Additionally, we actively cultivate community partnerships to improve patient access to comprehensive services.

The multi‑year renewal strengthens ABL’s integrated platform, improving revenue visibility and supporting the Group’s ...

The latent TB testing market presents opportunities through government support, tech advances in multiplex and molecular diagnostics, POC testing, telemedicine, and personalized medicine. These ...

The renewed and expanded agreements provide improved commercial conditions, including more competitive pricing, optimized contractual terms, and enhanced supply security. These improvements will ...

Strong Buy reiterated with a €8.37 target price following the 21 January 2026 Flash; last close on 22 January 2026: ...

Researchers now recognize eight different trajectories after COVID infection; some are severely ill many months later.

The difficulty is that EBV lives latently in B cells in the blood at a frequency, in most immunocompetent individuals, of about 1 in 100,000 to 1 in a million. That level of infection is below the ...

Zimbabwe, where HIV has led to tens of thousands of deaths over the past two decades, is one of the first countries to roll out lenacapavir, a long-acting drug that authorities hope will slow new ...

It's easier than ever to test for sexually transmitted infections at home. We break down whether or not you should. Getting tested for sexually transmitted infections can feel complex, confusing, or ...

He told me he had just learned from his doctor that he has AIDS. He then confessed that he’d had an affair with a contractor ...